These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23658784)

  • 1. Characterization of acid sphingomyelinase activity in human cerebrospinal fluid.
    Mühle C; Huttner HB; Walter S; Reichel M; Canneva F; Lewczuk P; Gulbins E; Kornhuber J
    PLoS One; 2013; 8(5):e62912. PubMed ID: 23658784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mRNA Expression of
    Rhein C; Zoicas I; Marx LM; Zeitler S; Hepp T; von Zimmermann C; Mühle C; Richter-Schmidinger T; Lenz B; Erim Y; Reichel M; Gulbins E; Kornhuber J
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages.
    Rozenova KA; Deevska GM; Karakashian AA; Nikolova-Karakashian MN
    J Biol Chem; 2010 Jul; 285(27):21103-13. PubMed ID: 20236926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory sphingomyelinase in health and disease.
    Kornhuber J; Rhein C; Müller CP; Mühle C
    Biol Chem; 2015 Jun; 396(6-7):707-36. PubMed ID: 25803076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of acid sphingomyelinase disrupts LYNUS signaling and triggers autophagy.
    Justice MJ; Bronova I; Schweitzer KS; Poirier C; Blum JS; Berdyshev EV; Petrache I
    J Lipid Res; 2018 Apr; 59(4):596-606. PubMed ID: 29378782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
    Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
    Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.
    Jones I; He X; Katouzian F; Darroch PI; Schuchman EH
    Mol Genet Metab; 2008 Nov; 95(3):152-62. PubMed ID: 18815062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Acid Sphingomyelinase Activity Is Associated with Biomarkers and Phenotypes of Alcohol Use and Dependence in Patients and Healthy Controls.
    Mühle C; Weinland C; Gulbins E; Lenz B; Kornhuber J
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30551571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Forebrain-Specific Overexpression of Acid Sphingomyelinase Induces Depressive-Like Symptoms in Mice.
    Zoicas I; Schumacher F; Kleuser B; Reichel M; Gulbins E; Fejtova A; Kornhuber J; Rhein C
    Cells; 2020 May; 9(5):. PubMed ID: 32443534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.
    Andrews NW
    Cell Microbiol; 2019 Nov; 21(11):e13065. PubMed ID: 31155842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of secretory sphingomyelinase is increased in plasma of alcohol-dependent patients.
    Reichel M; Beck J; Mühle C; Rotter A; Bleich S; Gulbins E; Kornhuber J
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1852-9. PubMed ID: 21595704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL death receptor 4 signaling via lysosome fusion and membrane raft clustering in coronary arterial endothelial cells: evidence from ASM knockout mice.
    Li X; Han WQ; Boini KM; Xia M; Zhang Y; Li PL
    J Mol Med (Berl); 2013 Jan; 91(1):25-36. PubMed ID: 23108456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous Smpd1 deficiency aggravates brain ischemia/ reperfusion injury by mechanisms involving polymorphonuclear neutrophils, whereas heterozygous Smpd1 deficiency protects against mild focal cerebral ischemia.
    Hagemann N; Mohamud Yusuf A; Martiny C; Zhang X; Kleinschnitz C; Gunzer M; Kolesnick R; Gulbins E; Hermann DM
    Basic Res Cardiol; 2020 Oct; 115(6):64. PubMed ID: 33057972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of acid sphingomyelinase in human various body fluids.
    Takahashi I; Takahashi T; Abe T; Watanabe W; Takada G
    Tohoku J Exp Med; 2000 Sep; 192(1):61-6. PubMed ID: 11128869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro.
    Naser E; Kadow S; Schumacher F; Mohamed ZH; Kappe C; Hessler G; Pollmeier B; Kleuser B; Arenz C; Becker KA; Gulbins E; Carpinteiro A
    J Lipid Res; 2020 Jun; 61(6):896-910. PubMed ID: 32156719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid sphingomyelinase deficiency in Western diet-fed mice protects against adipocyte hypertrophy and diet-induced liver steatosis.
    Sydor S; Sowa JP; Megger DA; Schlattjan M; Jafoui S; Wingerter L; Carpinteiro A; Baba HA; Bechmann LP; Sitek B; Gerken G; Gulbins E; Canbay A
    Mol Metab; 2017 May; 6(5):416-427. PubMed ID: 28462076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acid Sphingomyelinase (ASM) is a Negative Regulator of Regulatory T Cell (Treg) Development.
    Zhou Y; Salker MS; Walker B; Münzer P; Borst O; Gawaz M; Gulbins E; Singh Y; Lang F
    Cell Physiol Biochem; 2016; 39(3):985-95. PubMed ID: 27512981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The unconventional role of acid sphingomyelinase in regulation of retinal microangiopathy in diabetic human and animal models.
    Opreanu M; Tikhonenko M; Bozack S; Lydic TA; Reid GE; McSorley KM; Sochacki A; Perez GI; Esselman WJ; Kern T; Kolesnick R; Grant MB; Busik JV
    Diabetes; 2011 Sep; 60(9):2370-8. PubMed ID: 21771974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid sphingomyelinase regulates platelet cell membrane scrambling, secretion, and thrombus formation.
    Münzer P; Borst O; Walker B; Schmid E; Feijge MA; Cosemans JM; Chatterjee M; Schmidt EM; Schmidt S; Towhid ST; Leibrock C; Elvers M; Schaller M; Seizer P; Ferlinz K; May AE; Gulbins E; Heemskerk JW; Gawaz M; Lang F
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):61-71. PubMed ID: 24233488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASM is a therapeutic target in dermatomyositis by regulating the differentiation of naive CD4 + T cells into Th17 and Treg subsets.
    Chen Y; Liu H; Luo Z; Zhang J; Dong M; Yin G; Xie Q
    Skelet Muscle; 2024 Jul; 14(1):16. PubMed ID: 39026344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.